ARID1B Gene Mental retardation autosomal dominant type 12 Genetic Test
Welcome to DNA Labs UAE, where we offer the ARID1B Gene Mental retardation autosomal dominant type 12 Genetic Test. This test is designed to identify mutations in the ARID1B gene that may be causing mental retardation, autosomal dominant type 12 (MRD12).
Test Details
The ARID1B gene is responsible for producing a protein called AT-rich interactive domain-containing protein 1B, which plays a crucial role in brain development and function. MRD12 is a genetic disorder characterized by intellectual disability, delayed speech and language development, and other developmental delays. Individuals with MRD12 may also exhibit distinctive facial features, such as a prominent forehead and widely spaced eyes.
NGS Technology
Our ARID1B Gene Mental retardation autosomal dominant type 12 Genetic Test utilizes Next-Generation Sequencing (NGS) technology. NGS genetic testing allows for the simultaneous analysis of multiple genes, including the ARID1B gene. By examining variations or mutations in the ARID1B gene, we can provide important information for diagnosis, genetic counseling, and management of individuals with MRD12.
Test Components and Price
- Components: ARID1B Gene Mental retardation autosomal dominant type 12 Genetic Test
- Price: 4400.0 AED
Sample Condition
We accept the following sample conditions for the test:
- Blood
- Extracted DNA
- One drop of blood on FTA Card
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Test Type and Department
The ARID1B Gene Mental retardation autosomal dominant type 12 Genetic Test falls under the category of Neurological Disorders and is conducted by our Genetics department.
Doctor and Pre Test Information
The test is recommended to be conducted under the supervision of a Neurologist. Prior to the test, a Genetic Counselling session will be conducted to gather the clinical history of the patient and draw a pedigree chart of family members affected by ARID1B Gene Mental retardation, autosomal dominant type 12.
It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals specializing in genetics. Our team of experts can provide appropriate counseling and support to individuals and families undergoing genetic testing.
Test Name | ARID1B Gene Mental retardation autosomal dominant type 12 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ARID1B Gene Mental retardation, autosomal dominant type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARID1B Gene Mental retardation, autosomal dominant type 12 |
Test Details |
The ARID1B gene is a gene that provides instructions for making a protein called AT-rich interactive domain-containing protein 1B. This protein is involved in regulating the activity of other genes, specifically those that are important for normal development and function of the brain. Mental retardation, autosomal dominant type 12 (MRD12) is a genetic disorder caused by mutations in the ARID1B gene. This condition is characterized by intellectual disability, delayed speech and language development, and other developmental delays. Individuals with MRD12 may also have distinctive facial features, such as a prominent forehead and widely spaced eyes. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ARID1B gene-related disorders like MRD12, NGS genetic testing can be used to identify mutations or variations in the ARID1B gene that may be causing the condition. NGS genetic testing can provide important information for diagnosis, genetic counseling, and management of individuals with MRD12. It can help confirm a clinical diagnosis, identify individuals at risk of inheriting the condition, and guide treatment decisions or interventions. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. They can provide appropriate counseling and support to individuals and families undergoing genetic testing. |